FairScope Lab
EN 繁中 简中

PFE

Valuation Healthcare · Drug Manufacturers - General Data as of 2026-06-30

P/E Ratio · Metrics

P/E Ratio

-

PEG Ratio

-

Dividend Yield

-

Gross Margin

72.78%

Net Margin

-1.64%

Revenue CAGR 3Y

5.69%

ROE

-1.16%

ROA

-0.49%

Buyback Yield

0.56%

Current Ratio

1.27

Magic Earn Yield

0.03%

Altman Z-Score

1.62

Fair Value River

Score

Valuation 0
Profitability 18
Growth 19
Health 37
Yield 9
← Back to Dashboard